Literature DB >> 26192772

Precautions surrounding blood transfusion in autoimmune haemolytic anaemias are overestimated.

Salih Yürek1, Beate Mayer1, Mohammed Almahallawi1, Axel Pruss1, Abdulgabar Salama1.   

Abstract

BACKGROUND: It is very evident that many precautions are taken regarding transfusion of red blood cells in patients with autoimmune haemolytic anaemia. Frequently, considerable efforts are made to examine the indication and serological compatibility prior to transfusion in such patients. However, at times, this may unnecessarily jeopardize patients who urgently require a red blood cell transfusion.
MATERIALS AND METHODS: Thirty-six patients with warm-type autoimmune haemolytic anaemia were included in this study. All patients had reactive serum autoantibodies and required blood transfusion. Standard serological assays were employed for the detection and characterization of antibodies to red blood cells.
RESULTS: A positive direct antiglobulin test was observed in all 36 patients, in addition to detectable antibodies in both the eluate and serum. Significant alloantibodies were detected in the serum samples of three patients (anti-c, anti-JK(a), and anti-E). In 32 patients, red blood cell transfusion was administered with no significant haemolytic transfusion reactions due to auto- and/or allo-antibodies. Due to overestimation of positive cross-matches three patients received no transfusion or delayed transfusion and died, and one patient died due to unrecognised blood loss and anaemia which was attributed to an ineffective red blood cell transfusion. DISCUSSION: Many of the reported recommendations regarding transfusion of red blood cells in autoimmune haemolytic anaemia are highly questionable, and positive serological cross-matches should not result in a delay or refusal of necessary blood transfusions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26192772      PMCID: PMC4624538          DOI: 10.2450/2015.0326-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  31 in total

Review 1.  Red blood cell transfusion in autoimmune hemolytic anemia.

Authors:  Orin W Buetens; Paul M Ness
Journal:  Curr Opin Hematol       Date:  2003-11       Impact factor: 3.284

2.  A life-threatening paediatric case of acute autoimmune haemolytic anaemia (AIHA) successfully cured by plasma-exchange and combined immunosuppressive treatment.

Authors:  G Lucchini; N Masera; G Foti; G Assali; P Perseghin; E Biagi
Journal:  Transfus Apher Sci       Date:  2009-02-23       Impact factor: 1.764

3.  Autoimmune haemolytic anaemia associated with mantle cell lymphoma.

Authors:  Heather E Eve; Simon A J Rule
Journal:  Int J Hematol       Date:  2010-03       Impact factor: 2.490

4.  Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells.

Authors:  A Salama; C Mueller-Eckhardt
Journal:  Transfusion       Date:  1984 May-Jun       Impact factor: 3.157

Review 5.  Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment.

Authors:  Melca M O Barros; Morris A Blajchman; José O Bordin
Journal:  Transfus Med Rev       Date:  2010-07

6.  Successful control of refractory and life-threatening autoimmune hemolytic anemia with intravenous immunoglobulins in a man with the primary antiphospholipid syndrome.

Authors:  P Vandenberghe; P Zachee; S Verstraete; H Demuynck; M A Boogaerts; G E Verhoef
Journal:  Ann Hematol       Date:  1996-11       Impact factor: 3.673

Review 7.  Mixed-type autoimmune hemolytic anemia: differential diagnosis and a critical review of reported cases.

Authors:  Beate Mayer; Salih Yürek; Holger Kiesewetter; Abdulgabar Salama
Journal:  Transfusion       Date:  2008-06-28       Impact factor: 3.157

Review 8.  A physician's guide to transfusion in autoimmune haemolytic anaemia.

Authors:  Lawrence D Petz
Journal:  Br J Haematol       Date:  2004-03       Impact factor: 6.998

9.  Successful management of concurrent congenital dyserythropoietic anaemia and autoimmune haemolytic anaemia with splenectomy.

Authors:  M L Schmidt; S Joshi; P J DeChristopher; M Mihalov; S D Sosler
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

Review 10.  Transfusion therapy in autoimmune hemolytic anemia.

Authors:  L C Jefferies
Journal:  Hematol Oncol Clin North Am       Date:  1994-12       Impact factor: 3.722

View more
  3 in total

Review 1.  Clinically and/or Serologically Misleading Findings Surrounding Immune Haemolytic Anaemias.

Authors:  Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-10       Impact factor: 3.747

Review 2.  Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review.

Authors:  Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-10       Impact factor: 3.747

3.  Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions.

Authors:  Chunxia Chen; Lixin Wang; Bing Han; Li Qin; Binwu Ying
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.